货号：UP176570136
| 产品信息 | |
| 产品名称： | AZD6738 |
| 中文名称： | AZD6738(请以英文为准,中文仅做参考) |
| CAS号： | 1352226-88-0 |
| 分子式： | C20H24N6O2S |
| 分子量： | 412.51 |
| MDL NO： | N/A |
| 标准纯度： | 98+% (UP176570136) |
| 沸点： | - |
| 储存： | Sealed in dry,2-8°C (UP176570136) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Bromodeoxyuridine
UP40468322959-14-3
GBR 12935 dihydrochloride
UP64365638467469-81-2
(-)-Blebbistatin
UP745702649856925-71-8
QL47
UP7387848951469988-75-7
LY3039478
UP3695146261421438-81-4
TAK-438 free base
UP161331384881681-00-1
(R)-Flurbiprofen
UP35022607251543-40-9
R1487 Hydrochloride
UP634180337449808-64-4
KS176
UP2197429221253452-78-6
AM095 free acid
UP2874924681228690-36-5
NF449
UP326245241627034-85-9
LOXO-101 sulfate
UP7557934351223405-08-0
NVP-BVU972
UP9313039761185763-69-2
tert-Butyl (((tert-butoxycarbonyl)amino)(1H-pyrazol-1-yl)methylene)carbamate
UP663081594152120-54-2
4-Nitrophenyl-β-D-glucopyranoside
UP4111098892492-87-7
sitaxsentan
UP203618155184036-34-8
Glycyrrhizic acid
UP6034591611405-86-3
Vanoxerine
UP15288651667469-69-6
Su5205
UP2472844563476-86-6
Ruxolitinib
UP195054792941678-49-5
IKKε-IN-1
UP7372008501292310-49-6
DDR1-IN-1
UP4774828001449685-96-4
Rosuvastatin
UP356085330287714-41-4
(R)-Baclofen
UP90993720069308-37-8
LY2801653
UP5546253841206799-15-6
BMS-582949 hydrochloride
UP489685950912806-16-7
5-Aminosalicylic Acid
UP47245791589-57-6
KY1220
UP767549936292168-79-7
Velneperit
UP274454514342577-38-2
Mutant IDH1 inhibitor
UP9158681161429180-08-4
EHop-016
UP2548159321380432-32-5
A-317491
UP921996684475205-49-3
LY2409881 trihydrochloride
UP953910893946518-60-1
Felbamate hydrate
UP6659999481177501-39-1
Linsitinib
UP832628882867160-71-2
N-Desethyl Sunitinib
UP327760612356068-97-8
Sarcosine
UP431337739107-97-1
S49076
UP7673069451265965-22-7
AZD0865
UP263558218248919-64-4
Ridaforolimus
UP931478838572924-54-0
D609
UP11111266783373-60-8
JNJ-31020028
UP6585156301094873-14-9
Tariquidar
UP661657182206873-63-4
AZD6738
UP1765701361352226-88-0